Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer Inc. boosts its oncology pipeline with strategic control of PD-1/VEGF bispecific drugs via 3SBio deal. Click for more ...

According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...

Given the recent price decline and the context of its financial performance, investors may closely monitor One 97 ...

With the current price at Rs 395.10, Hindustan Petroleum Corporation's stock movement reflects ongoing market dynamics and ...

Real-time index price for TSX American Preferred Stock Index (STNC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Real-time index price for Nasdaq Transportation Index (NAST), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

which tends to hurt stock performance. The strategy also had less exposure to highly liquid stocks compared with Morningstar Category peers in recent months. Less-liquid stocks might offer strong ...